Clinical trial
Genetic Analysis of Toxicity Associated With High-Dose Melphalan
NCT00602147 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Analysis of Toxicity Associated With High-Dose Melphalan
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 31, 2007
- Completion date
- April 30, 2010
- Enrollment
- 95 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
mucositis, multiple myeloma and plasma cell neoplasm